Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
Clinical trial NCT03101566 · COMPLETED
Trial details
- NCT number
- NCT03101566
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2019-12-03
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.